Beijing drafts first clinical pathway of novel coronavirus cases


Beijing drafted China's first clinical pathway of the novel coronavirus cases in the capital to improve the recovery rate for the disease, in accordance with hospitalization process, medical diagnosis and nursing care for infected patients, according to a Wednesday media briefing in Beijing on battling the virus.
The first edition of the clinical pathway of novel coronavirus cases in Beijing include show suspected cases and those confirmed would be treated at hospitals, and differentiating individual treatment plans for the infected based on their severity.
Issuing the capital's novel coronavirus clinical pathway is aimed at helping more clinical doctors to provide convenience in tracking a patient's disease in diagnosis and standardizing the diagnostic process.
The clinical pathway of Beijing's novel coronavirus cases had already been made public Tuesday on the official websites of Beijing Medical Association and Beijing Medical Doctor Association.
- Trial of 21-member cross-border crime group ends in Shenzhen
- Shanghai Jiao Tong Uni fosters collaborative research through China-Oceania forum
- Global scientists gather at 2025 Pujiang Innovation Forum in Shanghai
- UNESCO inaugurates STEM education institute in Shanghai
- China, US should avoid conflict, defense chief says
- China's 'Dual Carbon' Entrepreneur Stories